Company’s data offering, powered by its proprietary underwater vehicles, aims to expand access to ocean observation the way CubeSats transformed earth observation CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apeiron Labs, which is building a platform to deliver real-time ocean…
Funding will accelerate automation of administrative workflows across the entire patient journey using multi-agent AI, helping providers focus on patient care CAMBRIDGE, Mass.–(BUSINESS WIRE)–Synthpop, Inc., a healthcare AI company building agentic automation to eliminate administrative…
Cambridge, MA – Bicycle Therapeutics plc has announced the appointment of Michael Skynner as Chief Technology Officer. About Bicycle Therapeutics plc: Bicycle Therapeutics (NASDAQ: BCYC) is a biotechnology company focused on developing precision-guided therapeutics, primarily…
Cambridge, MA – Convergent Therapeutics has announced the appointment of Elizabeth Montgomery as Chief People Officer. About Convergent Therapeutics: Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to…
Cambridge, MA – Gensaic Inc. has announced the appointment of Nathan Higginson-Scott as Chief Research & Development Officer. About Gensaic Inc.: Gensaic combines AI-powered protein design with unbiased directed evolution to develop tissue-selective ligands for…
According to filings with the U.S. Securities and Exchange Commission, Reservoir Power is raising up to $4,599,999.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
According to filings with the U.S. Securities and Exchange Commission, Malta is raising up to $23,991,500.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities…
Initial $75M Series A investment from founding investors Atlas Venture, LAV and venBio in April 2025, recently augmented by $37.5M Series A-1 funding led by Omega Funds, with participation from additional new investors Wellington Management…
CAMBRIDGE, Mass., Jan. 7, 2026 /PRNewswire/ — STRM.BIO, a biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced $8 million in Series Seed 2 financing. The financing provided by Recordati was supported by continued…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation…